| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |